adagrasib
mirati
['adagrasib', 'lung', 'lcsm,(-blcsm)']
more than 40% of patients with kras g12c-mutated non-small cell lung cancer responded to treatment with adagrasib, reported alexander spira, md, phd, at #asco22. by , . #lcsm #oncotwitter 
Restore medicine to its mission.